Yamamoto, Senri
Iihara, Hirotoshi
Uozumi, Ryuji
Kawazoe, Hitoshi
Tanaka, Kazuki
Fujita, Yukiyoshi
Abe, Masakazu
Imai, Hisao
Karayama, Masato
Hayasaki, Yoh
Hirose, Chiemi
Suda, Takafumi
Nakamura, Kazuto
Suzuki, Akio
Ohno, Yasushi
Morishige, Ken-ichirou
Inui, Naoki
Article History
Received: 28 April 2021
Accepted: 8 July 2021
First Online: 19 July 2021
Declarations
:
: Study 1 was approved by the Medical review board of Hamamatsu University Graduate School of Medicine (16–296). Studies 2 and 3 were approved by the Medical review board of Gifu University Graduate School of Medicine (30–002, 2018–19). These studies were conducted according to the Declaration of Helsinki and the ethical guidelines for clinical studies. Written informed consent was obtained from all patients. For this integrated study, study 1 was as an opt-out method for the secondary use of data with the approval of the Medical review board of Hamamatsu University Graduate School of Medicine (20–335), and for study 2 and 3, patient written informed consent was obtained for the secondary use of data.
: Not applicable.
: The authors declare that they have no competing interests.